Summary of key findings from the HFSA 2025 presentation on Cardiac Contractility Modulation (CCM) therapy. This real-world study demonstrates CCM's significant impact in reducing mortality and heart failure hospitalizations compared to a matched control group, highlighting its effectiveness in improving long-term survival for heart failure patients.
Analysis of real-world survival rates for Cardiac Contractility Modulation (CCM®) compared to Cardiac Resynchronization Therapy (CRT) using the Truveta™ database, detailing study objectives, design, and key findings.